SCHEMBL5513071

SCHEMBL5513071

COc1ccc(/C=C/C(=O)OCC(O)CO)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.61
LMNA P02545 2/20 0.61
GSK3B P49841 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.54
F3 P13726 2/20 0.54
THRB P10828 1/20 0.53
ATM Q13315 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPT P10636 1/20 0.51
CASP3 P42574 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
GAA P10253 1/20 0.51
RAB9A P51151 2/20 0.50
HDAC3 O15379 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4212357 1.00 TDP1 (0.61) TDP1LMNAGSK3BSMN1; SMN2F3
4-Methoxycinnamic Acid SCHEMBL16333598 0.95 THRB (0.62) TDP1LMNAGSK3BSMN1; SMN2F3
SCHEMBL8750788 0.87 TDP1 (0.46) TDP1LMNAGSK3BSMN1; SMN2MAPT
SCHEMBL20010336 0.86 TDP1 (0.68) TDP1LMNAGSK3BSMN1; SMN2F3
2-Ethylhexanoic Acid SCHEMBL5969968 0.85 TDP1 (0.66) TDP1LMNAGSK3BSMN1; SMN2THRB
SCHEMBL27945826 0.84 TDP1 (0.74) TDP1LMNAGSK3BSMN1; SMN2F3
SCHEMBL20475032 0.84 TDP1 (0.74) TDP1LMNAGSK3BSMN1; SMN2F3
SCHEMBL14487924 0.84 TDP1 (0.59) TDP1LMNAGSK3BSMN1; SMN2F3
SCHEMBL8750789 0.84 TDP1 (0.44) TDP1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL1660425 0.83 TNFRSF1A (0.60) TDP1LMNASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106309421-B Pharmaceutical composition and cosmetic composition 沃凯索法株式会社 2020-08-25 CN disclosed
CN-104136498-B Novel liquid organopolysiloxanes and use thereof 道康宁东丽株式会社 2017-06-20 CN disclosed
CN-104136498-A Novel liquid organopolysiloxanes and use thereof DOW CORNING TORAY CO LTD 2014-11-05 CN disclosed
WO-2012010554-A1 USE OF COMPOUNDS RESULTING FROM A SUGAR POLYOL OR FROM A DEHYDROGENATED SUGAR POLYOL DERIVATIVE AS A UV-SCREENING AGENT; ANTISUN COMPOSITIONS CONTAINING SAME; AND NOVEL COMPOUNDS L'OREAL (FR) 2012-01-26 WO disclosed
US-7863478-B2 1,3-Bis-[3-(4-methoxyphenyl)-2-propenoyloxy]-2-oxopropane; novel alpha-hydroxyketone derivatives as light-protection filters for cosmetic or drug products; used in cosmetic protective coatings; solar radiation; sunscreen agents; aging resistance; wrinkle resistance; food additives; dermatology MERCK PATENT GMBH (DE) 2011-01-04 US disclosed
US-7863478-B2 1,3-Bis-[3-(4-methoxyphenyl)-2-propenoyloxy]-2-oxopropane; novel alpha-hydroxyketone derivatives as light-protection filters for cosmetic or drug products; used in cosmetic protective coatings; solar radiation; sunscreen agents; aging resistance; wrinkle resistance; food additives; dermatology MERCK PATENT GMBH (DE) 2011-01-04 US disclosed
US-20080038213-A1 Uv Filters MERCK PATENT GMBH (DE) 2008-02-14 US disclosed
US-20080038213-A1 Uv Filters MERCK PATENT GMBH (DE) 2008-02-14 US disclosed
US-7285294-B2 Hair growth inhibitors and composition containing same SHISEIDO COMPANY, LTD. (JP) 2007-10-23 US disclosed
US-20050175576-A1 Hair growth inhibitors and composition containing same SHISEIDO CO., LTD. (JP) 2005-08-11 US disclosed
EP-1352637-A1 HAIR GROWTH INHIBITORS AND COMPOSITIONS CONTAINING THE SAME SHISEIDO COMPANY LIMITED (JP) 2003-10-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080038213-A1 Uv Filters ERCC4, ERCC1, ERCC5 TDP1 1260/4885LMNA 236/4885GSK3B 4403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.